Integrative Transcriptomic Meta-Analysis Reveals SIRT1-SNCA Correlation in Parkinson's Disease

Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects midbrain dopaminergic neurons, with no approved therapeutic treatments available. Identifying candidate molecular targets that are consistent across various models, such as postmortem human brain, iPSC-derived models, and dopaminergic cell lines, has been challenging, hindering clinical translation.

To address this issue, researchers conducted an integrative transcriptomic meta-analysis of 33 publicly available datasets from the mentioned model systems. They combined differential expression and functional enrichment analyses with STRING protein-protein interaction networks, followed by drug-gene interaction screening using a polyphenol panel. Surprisingly, resveratrol emerged as a common factor in all 33 comparisons, regardless of the model system, tissue, or genetic background.

The analysis revealed that resveratrol is associated with 30 distinct target genes, with SIRT1 being a recovered target in 6 of the comparisons, spanning all three model systems. Furthermore, the researchers resolved the SIRT1-SNCA relationship into four directional patterns that varied depending on the model system, with an inverse relationship observed in postmortem brain tissue and a positive relationship in acutely toxin-exposed cells.

These findings provide evidence for a candidate, context-dependent resveratrol-SIRT1 axis in Parkinson's disease.